← Back to all trials
Completed
NCT05679505
VAGUS NERVE STIMULATION FOR POST COVID-19 SYNDROME
Conditions: Long COVID, Vagus Nerve Stimulations, Heart Rates, Autonomic Nervous System Disorders
Sex: All
Ages: 18 Years – 45 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 40
Sponsor: Bahçeşehir University
Location: Turkey
Summary
The aim of this study is to increase parasympathetic activity and decrease the severity of symptoms by providing vagal stimulation with the t-VNS method in order to suppress the increased sympathetic activity in patients with prolonged Covid symptoms.The main question[s] it aims to answer are:Question 1:Is left ear transcutaneous vagus nerve stimulation effective in suppressing the symptoms of patients in Post Covid syndrome?Question 2:Is bilateral auricular transcutaneous vagus nerve stimulation effective in suppressing the symptoms of patients in Post Covid syndrome?A 5-minute heart rate variability measurement will be performed to measure the effectiveness of vagus nerve stimulation in participants.HRV is a non-invasive method used to evaluate ANS activity and is a measure of heart rate change over a period of time
Eligibility Criteria
Inclusion Criteria:Being 18 years or olderExperiencing at least one of the post-covid symptoms for 12 weeks or longerExclusion Criteria:Considering that the female reproductive hormones level in the body and menstrual cycle may affect the ANS in female patients, female participants in perimenopausal, post-menopausal and pregnancy conditions were excluded from the study.Participants who used medication for the treatment of ANS dysfunction in the last six months were also excluded from the study.
Source: ClinicalTrials.gov (NCT05679505). StuddyBuddy aggregates publicly available trial information.